Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 07.09.2026 1 Acta Neuropathol 1 Alzheimer Dis Assoc Disord 7 Alzheimers Dement 1 Am J Alzheimers Dis Other Demen 1 Am J Geriatr Psychiatry 1 Br J Psychiatry 2 Curr Alzheimer Res 1 Drugs 20 J Alzheimers Dis 1 J Neurol 1 Lancet 3 Nat Neurosci 1 Nat Rev Neurol 2 Neurology 2 Neuroreport

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. MASTRANGELO A, Baiardi S, Ruggeri E, Bentivenga GM, et al
   Changes in five cerebrospinal fluid and three plasma Alzheimer's disease biomarkers across increasing brain amyloid-beta and tau pathology burden.
   Acta Neuropathol. 2026;152:28.
   PubMed         Abstract available
   
   

   
   Alzheimer Dis Assoc Disord

2. HORN J, Knox S
   Representation of Alzheimer Disease and Related Dementias in a Statewide Population Genomics Cohort: Early Findings from In Our DNA SC.
   Alzheimer Dis Assoc Disord. 2026 Aug 31. doi: 10.1097/WAD.0000000000000750.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

3. SUN W, Yang B, Zheng H, Wang Q, et al
   Extracellular matrix remodeling upregulates hippocampal neurogenic niche stiffness and impairs neurogenesis in Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71784.
   PubMed         Abstract available
   
   
4. LAN G, Liao W, Jiang M, Zhu J, et al
   Longitudinal plasma phosphorylated tau217 classification and the association with Alzheimer's disease progression.
   Alzheimers Dement. 2026;22:e71783.
   PubMed         Abstract available
   
   
5. SHVETCOV A, Thomson S, Graham ME, Hauger B, et al
   Cross-tissue immune profiling of APOE epsilon4 reveals early dysregulation in Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71714.
   PubMed         Abstract available
   
   
6. XU M, Gao Y, Ou P, Yang H, et al
   Female vulnerability to microvascular transport dysfunction emerges early across the Alzheimer's disease continuum.
   Alzheimers Dement. 2026;22:e71811.
   PubMed         Abstract available
   
   
7. QI L, Wang W, Abdullah R, Zhao Y, et al
   Neurobiological mechanisms of 40-Hz stimulation in Alzheimer's disease: evidence, heterogeneity, and constraints.
   Alzheimers Dement. 2026;22:e71806.
   PubMed         Abstract available
   
   
8. DENKINGER MN, Brum WS, Leuzy A, Singh A, et al
   Brain-derived plasma p-tau217 shows enhanced dynamic range for Alzheimer's disease neuropathological change.
   Alzheimers Dement. 2026;22:e71773.
   PubMed         Abstract available
   
   
9. DUBBELMAN MA, Hill-Jarrett TG, Chapman S, Alves Andrade Dos Santos G, et al
   A world view: Considerations of sociocultural diversity in the study of subjective cognitive decline in Alzheimer's disease and related dementias.
   Alzheimers Dement. 2026;22:e71779.
   PubMed         Abstract available
   
   

   
   Am J Alzheimers Dis Other Demen

10. AIELLO EN, De Luca G, Moreschi A, Curti B, et al
    Are the "Serial 7s" and Spelling Backwards Tasks From the MMSE Comparable in MCI and Dementia?
    Am J Alzheimers Dis Other Demen. 2026;41:15333175261449026.
    PubMed         Abstract available
    
    

    
    Am J Geriatr Psychiatry

11. CLARK ED, Perin J, Devanand DP, Padala PR, et al
    Effects of Escitalopram on Neuropsychiatric Symptoms in Alzheimer Disease: A Secondary Analysis From the S-CitAD Study.
    Am J Geriatr Psychiatry. 2026 Aug 12:S1064-7481(26)00498.
    PubMed         Abstract available
    
    

    
    Br J Psychiatry

12. HAMILTON CA, Donaghy PC, Taylor JP, Ciafone J, et al
    Cross-sectional and longitudinal associations between depressive symptoms and cognitive performance in mild cognitive impairment.
    Br J Psychiatry. 2026;229:286-291.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

13. MA J, Wei Z, Rong C, He W, et al
    The Relationship Between Biomarkers in Blood and Urine and Alzheimer's Disease and Sleep Disorders (Long Sleep): A Mendelian Randomization Study.
    Curr Alzheimer Res. 2026 Aug 19. doi: 10.2174/0115672050466562260804080255.
    PubMed         Abstract available
    
    
14. SURA S, Okwuofu EO, Ramakrishnappa S, Jagadeesan S, et al
    Structural and Ultrastructural Neuropathological Changes in Alzheimer's Disease: Biomarkers, Current Insights and Emerging Perspectives.
    Curr Alzheimer Res. 2026 Aug 20. doi: 10.2174/0115672050468141260805043246.
    PubMed         Abstract available
    
    

    
    Drugs

15. HEY JA, Abushakra S, Power A, Watson D, et al
    Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer's Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes.
    Drugs. 2026 Sep 1. doi: 10.1007/s40265-026-02381.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

16. RICCIOPPO RODRIGUES G
    Diluting the signal: Class-level pooling and the ecological fallacy in meta-analyses of anti-amyloid monoclonal antibodies.
    J Alzheimers Dis. 2026;113:95-96.
    PubMed         Abstract available
    
    
17. WEISS JN, Eber D, Cole R
    Dynamic light scattering spectroscopy and the Centiloid scale.
    J Alzheimers Dis. 2026;113:271-278.
    PubMed         Abstract available
    
    
18. AGUERO-RABES P, Roa-Escobar J, Tellez R, Mananes V, et al
    Eligibility for lecanemab therapy in a biomarker defined memory clinic cohort: A five-year analysis.
    J Alzheimers Dis. 2026;113:89-94.
    PubMed         Abstract available
    
    
19. SHARMA A, Suresh V, Kola PR, Raj R, et al
    Comparative risk of amyloid-related imaging abnormalities with anti-amyloid-beta monoclonal antibodies: A systematic review and penalized likelihood network meta-analysis of randomized trials.
    J Alzheimers Dis. 2026;113:65-82.
    PubMed         Abstract available
    
    
20. NONG Y, Wellman S, Zhang H, Liu YA, et al
    Long-term locus coeruleus stimulation exacerbates tau pathology in PS19 mice.
    J Alzheimers Dis. 2026;113:234-249.
    PubMed         Abstract available
    
    
21. FANG Q, Guo Y, Chen L, Li Y, et al
    A multimodal machine learning model integrating plasma biomarkers and MRI metrics for non-invasive prediction of amyloid-beta pathology in mild cognitive impairment.
    J Alzheimers Dis. 2026;113:101-114.
    PubMed         Abstract available
    
    
22. CUSTODIO B, Montesinos R, Aguero K, Huilca JC, et al
    Recruitment challenges and strategies for engaging the Peruvian population in the ReDLat Study.
    J Alzheimers Dis. 2026;113:224-233.
    PubMed         Abstract available
    
    
23. LIU Y, Qiu Q, Yue L, Hong B, et al
    Precuneus amyloid-beta deposition involving the association of irritability and cognitive decline: A multi-cohort longitudinal study.
    J Alzheimers Dis. 2026;113:198-215.
    PubMed         Abstract available
    
    
24. DENIER-FIELDS DN, Gangnon RE, Rivera-Rivera LA, Betthauser TJ, et al
    Better cardiovascular health, measured by Life's Simple 7, is associated with lower white matter hyperintensity burden and greater cerebral blood flow over time.
    J Alzheimers Dis. 2026;113:140-157.
    PubMed         Abstract available
    
    
25. JODLOWSKA-SIEWERT E, Liu L, Yang K, Ostroushko D, et al
    A score based on MRI imaging variables can predict time to moderate progression in mild cognitive impairment: Multimodal data integration study.
    J Alzheimers Dis. 2026;113:377-389.
    PubMed         Abstract available
    
    
26. RUIZ-GARCIA A, Diaz-Benito B, Munoz-Garcia M
    A hippocampal vascular-glymphatic model of brain maintenance and cognitive resilience in Alzheimer's disease and post-stroke dementia.
    J Alzheimers Dis. 2026 Aug 30:13872877261483191. doi: 10.1177/13872877261483191.
    PubMed         Abstract available
    
    
27. ZHANG W, Wang S, Gou X
    Research progress on terpenoids alleviating Alzheimer's disease through the Keap1/Nrf2/ARE pathway by exerting antioxidant effects and promoting mitophagy.
    J Alzheimers Dis. 2026 Aug 31:13872877261480043. doi: 10.1177/13872877261480043.
    PubMed         Abstract available
    
    
28. SHEN B, Zhu Z, Qing H, Quan Z, et al
    Key circuits through which sleep affects memory and their role in Alzheimer's disease.
    J Alzheimers Dis. 2026 Aug 31:13872877261479999. doi: 10.1177/13872877261479999.
    PubMed         Abstract available
    
    
29. ZHANG L, Liu T, He CH, Russo A, et al
    Single-cell transcriptomic atlas of Alzheimer's disease middle temporal gyrus reveals region, cell type, and sex specificity of gene expression with novel genetic risk for MERTK in female.
    J Alzheimers Dis. 2026 Sep 1:13872877261480719. doi: 10.1177/13872877261480719.
    PubMed         Abstract available
    
    
30. LEE E, Pyun JM, Jeong H, Bae YJ, et al
    Model-based ordering of the ALPS index among Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2026 Sep 1:13872877261480387. doi: 10.1177/13872877261480387.
    PubMed         Abstract available
    
    
31. ZHANG Q, Zhou Q, Yang M, Zou S, et al
    Non-pharmacological interventions for sleep improvement in Alzheimer's disease: A systematic review and meta-analysis.
    J Alzheimers Dis. 2026 Sep 1:13872877261480066. doi: 10.1177/13872877261480066.
    PubMed         Abstract available
    
    
32. FREITAG JM, Konen FF, Heck J, Jahn K, et al
    Memory, social cognition, and beyond: Neuropsychological markers differentiating Alzheimer's disease and frontotemporal dementia.
    J Alzheimers Dis. 2026 Sep 2:13872877261480113. doi: 10.1177/13872877261480113.
    PubMed         Abstract available
    
    
33. MATALLANA RINCON S, Orozco Lopez F, Galindo JF
    Computational identification of novel acetylcholinesterase inhibitors as potential treatments for Alzheimer's disease.
    J Alzheimers Dis. 2026 Sep 2:13872877261483260. doi: 10.1177/13872877261483260.
    PubMed         Abstract available
    
    
34. YANG X, Li X, Wang C, Duan A, et al
    A dual-branch time-frequency fusion network for EEG-based classification of Alzheimer's disease and frontotemporal dementia.
    J Alzheimers Dis. 2026 Sep 2:13872877261483197. doi: 10.1177/13872877261483197.
    PubMed         Abstract available
    
    
35. SAHUQUILLO R, Garcia-Perez E, Navarro B, Fernandez-Aguilar L, et al
    Machine learning classification of mild Alzheimer's disease using EEG during emotional processing.
    J Alzheimers Dis. 2026 Sep 2:13872877261483280. doi: 10.1177/13872877261483280.
    PubMed         Abstract available
    
    

    
    J Neurol

36. HOLLEMAN J, Kareholt I, Nasholm MS, Sorensen C, et al
    Insomnia symptoms and stress exposure interact in relation to Alzheimer's disease biomarkers.
    J Neurol. 2026;273:560.
    PubMed         Abstract available
    
    

    
    Lancet

37. SCHLACHETZKI Z, Rafii MS
    Late-onset seizures as a sentinel of Alzheimer's disease progression in Down syndrome.
    Lancet. 2026 Sep 3:S0140-6736(26)00959-1. doi: 10.1016/S0140-6736(26)00959.
    PubMed        
    
    

    
    Nat Neurosci

38. PARADISE V, Konrad-Vicario KD, Nguyen C, Sharif NA, et al
    Neuroproteasomes regulate endogenous tau paired helical filament formation in an APOE genotype- and age-dependent manner.
    Nat Neurosci. 2026;29:2151-2163.
    PubMed         Abstract available
    
    
39. KLIMMT J, Cardoso Goncalves C, Montgomery JV, Muller SA, et al
    A reproducible three-dimensional model of human brain tissue to investigate physiological and disease-associated microglia phenotypes.
    Nat Neurosci. 2026;29:2324-2340.
    PubMed         Abstract available
    
    
40. ROE JM, Jagust WJ, Landau SM, Harrison TM, et al
    Cortical thickness changes precede high levels of amyloid by at least 7 years.
    Nat Neurosci. 2026;29:2164-2175.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

41. BALLARD C, Doherty P, Ismail Z, Corbett A, et al
    Symptomatic treatment for Alzheimer disease: current evidence and future directions.
    Nat Rev Neurol. 2026 Sep 1. doi: 10.1038/s41582-026-01260.
    PubMed         Abstract available
    
    

    
    Neurology

42. SARKIS RA, Yang HS, Liu L, Lam AD, et al
    Association Between Alzheimer Pathology, Sleep, and Cognition in Patients With Late-Onset Unexplained Epilepsy.
    Neurology. 2026;107:e218476.
    PubMed         Abstract available
    
    
43. WAGEMANN O, Nuebling GS, Sandkuhler K, Wlasich E, et al
    Longitudinal Dynamics of the Blood Proteome Within the Alzheimer Spectrum in Down Syndrome.
    Neurology. 2026;107:e218494.
    PubMed         Abstract available
    
    

    
    Neuroreport

44. WANG Z, Liu M, Xu J, Liu Y, et al
    sAPPalpha acts as an endogenous ligand for TREM2 to regulate microglial survival and inflammatory responses in Alzheimer's disease.
    Neuroreport. 2026 Aug 20. doi: 10.1097/WNR.0000000000002307.
    PubMed         Abstract available
    
    
45. LI B, Zhang Z, Bao H, Wang Y, et al
    Treadmill exercise rescues cognitive deficits in Alzheimer's mice by repairing axonal mitochondrial transport and synaptic function.
    Neuroreport. 2026 Sep 1. doi: 10.1097/WNR.0000000000002300.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum